Maven Securities LTD Cyclacel Pharmaceuticals, Inc. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.04 - $8.03 $141,444 - $188,046	-23,418 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$8.02 - $11.0 $1.69 Million - $2.32 Million	-211,082 Reduced 90.01%	23,418 $123,000
Q2 2021 Aug 16, 2021	SELL	$7.59 - $10.48 $117,645 - $162,440	-15,500 Reduced 6.2%	234,500 $1.43 Million
Q1 2021 May 17, 2021	BUY	$6.86 - $9.24 $1.72 Million - $2.31 Million	250,000 New	250,000 $1.79 Million

Ticker CYCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,539,200
Market Cap $7.9M
Description
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.